Schond Greenway
No más puestos en curso
Fortuna: 283 202 $ al 31/05/2024
Perfil
Schond L.
Greenway is a former Executive Director-Strategy & IR at Halozyme Therapeutics, Inc. from 2013 to 2016.
He also worked as the VP-Investor Relations & Strategic Planning at DURECT Corp.
and as the Vice President-Healthcare at Barclays Capital, Inc. In 2016, he joined Mesoblast Ltd.
as the VP & Global Head-Investor Relations, a position he held until 2021.
From 2021 to 2022, he served as the Chief Financial Officer & Treasurer at Avalo Therapeutics, Inc. Currently, he is the Chief Financial Officer at Mind Medicine (MindMed), Inc. Mr. Greenway completed his undergraduate degree at Florida A&M University and holds an MBA from the University of Virginia Darden School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/04/2024 | 32 182 ( 0.05% ) | 283 202 $ | 31/05/2024 |
Antiguos cargos conocidos de Schond Greenway.
| Empresas | Cargo | Fin |
|---|---|---|
| MIND MEDICINE (MINDMED) INC. | Director Financiero/CFO | 03/05/2024 |
| AVALO THERAPEUTICS, INC. | Director Financiero/CFO | 14/02/2022 |
| MESOBLAST LIMITED | Contacto de Relaciones con Inversores | 01/02/2021 |
| HALOZYME THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/01/2016 |
| DURECT CORPORATION | Public Communications Contact | - |
Formación de Schond Greenway.
| Florida A&M University | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| MESOBLAST LIMITED | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| DURECT CORPORATION | Health Technology |
| MIND MEDICINE (MINDMED) INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
- Bolsa de valores
- Insiders
- Schond Greenway
